IPD
Showing 26 - 50 of 9,237
Streptococcus Pneumoniae Pneumonia, Streptococcus Pneumoniae Infection, Streptococcus Pneumoniae Infection Invasive Trial in
Recruiting
- Streptococcus Pneumoniae Pneumonia
- +3 more
- nasopharyngeal aspirate
-
Chía, Cundinamarca, ColombiaClinica Universidad De La Sabana
Jun 21, 2021
Cardiac Arrest Trial in Toronto (inhaled nitric oxide (iNO), Sham)
Recruiting
- Cardiac Arrest
- inhaled nitric oxide (iNO)
- Sham
-
Toronto, Ontario, Canada
- +3 more
May 11, 2023
Non-alcoholic Fatty Liver Disease Trial (GSK4532990)
Not yet recruiting
- Non-alcoholic Fatty Liver Disease
- (no location specified)
Oct 23, 2023
Systemic Lupus Erythematosus Trial (Belimumab, Standard of care)
Not yet recruiting
- Systemic Lupus Erythematosus
- Belimumab
- Standard of care
- (no location specified)
Jun 14, 2023
Ischaemic Stroke Trial in Hunan (Intravenous thrombolysis)
Recruiting
- Ischaemic Stroke
- Intravenous thrombolysis
-
Hunan, ChinaXiangya Hospital, Central South University
Jun 27, 2023
Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B
Active, not recruiting
- Hemophilia B
- AAV5-hFIX
-
Berlin, Germany
- +5 more
Jan 17, 2023
Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Self-administered survey at hospital
- +2 more
- (no location specified)
Oct 3, 2023
Asthma in Populations of African Descent
Completed
- Asthma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Transmission and Acquisition of Nontuberculous Mycobacteria
Recruiting
- Nontuberculous Mycobacterial Pulmonary Infection
- +3 more
- Epidemiologic investigation
-
Denver, ColoradoNational Jewish Health
Dec 1, 2023
Healthy Volunteers Trial in Hannover (CSL324, Placebo)
Recruiting
- Healthy Volunteers
- CSL324
- Placebo
-
Hannover, GermanyFraunhofer Institute for Toxicology and Experimental Medicine
Jan 28, 2023
Adenosine Deaminase and Immunoglobulin E in Chronic Spontaneous
Not yet recruiting
- Chronic Spontaneous Urticaria
- Adenosine deaminase serum level
- IgE antibodies serum level
- (no location specified)
Aug 7, 2023
Ovarian Cancer Trial in Paris (Fluorescence guided surgery)
Not yet recruiting
- Ovarian Cancer
- Fluorescence guided surgery
-
Paris, Ile-de-France, FranceAP-HP, Hôpital européen Georges-Pompidou
Nov 21, 2022
Healthy Trial in Randwick (CSL324, Placebo)
Completed
- Healthy
- CSL324
- Placebo
-
Randwick, AustraliaScientia Clinical Research Ltd
Oct 3, 2022
HIV Trial (CAB LA)
Not yet recruiting
- HIV Infections
- CAB LA
- (no location specified)
Nov 21, 2023
Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)
Not yet recruiting
- Influenza, Human
- aQIV
- QIV
-
Batumi, Georgia
- +16 more
Oct 11, 2023
Falling Trial in Omaha (Multidirectional Perturbations for Balance Control Assessment (60 perturbations), Multidirectional
Not yet recruiting
- Falling
- Multidirectional Perturbations for Balance Control Assessment (60 perturbations)
- Multidirectional Perturbations for Balance Control Assessment (150 perturbations)
-
Omaha, NebraskaUniversity of Nebraska-Omaha, Biomechanics Research Building
Oct 10, 2023
Evaluation of Muscle Contraction in People With PD Trial in Tel Aviv (EMG)
Recruiting
- Evaluation of Muscle Contraction in People With PD
- EMG
-
Tel Aviv, IsraelTel aviv medical center
Jan 12, 2023
Meralgia Paresthetica, Lateral Femoral Cutaneous Nerve Entrapment Trial in Al ?ayy Ath Thamin (High-Intensity Laser Therapy
Recruiting
- Meralgia Paresthetica
- Lateral Femoral Cutaneous Nerve Entrapment
- High-Intensity Laser Therapy (HILT)
- Sham High-Intensity Laser Therapy (Sham HILT)
-
Al Ḩayy Ath Thāmin, Giza, EgyptOutpatient clinic of faculty of physical therapy, Ahram Canadian
May 30, 2023
Palate; Wound Trial in San Antonio (Amnion-chorion Membrane, ActCel Cellulose Gauze)
Not yet recruiting
- Palate; Wound
- Amnion-chorion Membrane
- ActCel Cellulose Gauze
-
San Antonio, TexasUniversity of Texas Health Science Center at San Antonio (Dental
Jun 29, 2023
Sickle Cell Disease Trial in Netherlands, United Kingdom, United States (CSL889)
Recruiting
- Sickle Cell Disease
- CSL889
-
Chicago, Illinois
- +12 more
Oct 11, 2022
Tumors Trial in Worldwide (Letetresgene autoleucel)
Active, not recruiting
- Neoplasms
- Letetresgene autoleucel
-
Pittsburgh, Pennsylvania
- +5 more
Aug 7, 2023